Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

All

ATC	Name	B/G	Ingredients	Form	Price
R03AL02	COMBIVENT	B	Salbutamol (sulfate) - 2.5mg/2.5ml, Ipratropium bromide - 500mcg/2.5ml	Inhaltion solution with nebuliser	745,833 L.L
C09DA04	CO APROVEL	B	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	658,483 L.L
C09DA04	CO APROVEL	B	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	658,483 L.L
C09DA04	CONVERIUM PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	395,090 L.L
A12AX	CALPEROS D3 A SUCER	B	Vitamin D3 - 400IU, Calcium - 500mg	Tablet, chewable	667,890 L.L
A12AX	CI-CAL+D	B	Calcium citrate - 250mg, Vitamin D3 - 125IU	Tablet	796,899 L.L
A12AX	CI-CAL+D	B	Calcium citrate - 250mg, Vitamin D3 - 1,000IU	Tablet	1,118,077 L.L
A12AX	CI-CAL+D	B	Calcium citrate - 250mg, Vitamin D3 - 800IU	Tablet, chewable	804,962 L.L
C07AB07/C09CA	CONCOR T 2.5	B	Bisoprolol fumarate - 2.5mg, Telmisartan - 40mg	Tablet	1,163,209 L.L
C07AB07/C09CA	CONCOR T 2.5	B	Bisoprolol fumarate - 2.5mg, Telmisartan - 40mg	Tablet	2,209,797 L.L
C07AB07/C09CA	CONCOR T 5	B	Bisoprolol fumarate - 5mg, Telmisartan - 40mg	Tablet	1,457,748 L.L
C09DA06	CANDESARTAN / HYDROCHLOROTHIAZIDE BIOGARAN	G	Candesartan cilexetil - 16mg, Hydrochlorothiazide - 12.5mg	Tablet	327,898 L.L
C09DA06	CANDESARTAN / HYDROCHLOROTHIAZIDE BIOGARAN	G	Candesartan cilexetil - 8mg, Hydrochlorothiazide - 12.5mg	Tablet	327,898 L.L
S01CA01	CO-AVAZIR	G	Tobramycin - 0.3%, Dexamethasone - 0.1%	Drops suspension	193,513 L.L
C07BB07	CONCOR PLUS	B	Bisoprolol fumarate - 5mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	888,105 L.L
C07BB07	CONCOR PLUS	B	Bisoprolol fumarate - 10mg, Hydrochlorothiazide - 25mg	Tablet, film coated	1,249,926 L.L
C07FB07	CONCOR AM 2.5	B	Bisoprolol fumarate - 2.5mg, Amlodipine besylate - 5mg	Tablet, film coated	1,377,012 L.L
C07FB07	CONCOR AM 5	B	Bisoprolol fumarate - 5mg, Amlodipine besylate - 5mg	Tablet, film coated	1,377,012 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE C	G	Potassium chloride - 2.611g/l, Magnesium chloride, 6H2O - 5.33g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 190.505g/l, Sodium chloride - 204.54g/l	Injectable solution	L.L
R03DA55	CAMPHO-PNEUMINE AMINOPHYLLINE ENFANTS	G	Eucalyptol - 0.03g, Camphre - 0.04g, Gaiacol ethyl glycolate - 0.12g, Aminophylline - 0.06g	Suppository	284,127 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE D	G	Potassium chloride - 5.215g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 166.7g/l, Sodium chloride - 214.76g/l	Injectable solution	L.L
R03DA55	CAMPHO-PNEUMINE AMINOPHYLLINE ENFANTS	G	Eucalyptol - 0.03g, Camphre - 0.04g, Gaiacol ethyl glycolate - 0.12g, Aminophylline - 0.06g	Suppository	426,190 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE E	G	Potassium chloride - 2.611g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 7.00g/l, Sodium acetate, 3H2O - 190.505g/l, Sodium chloride - 205.49g/l	Injectable solution	L.L
R03DA55	CAMPHO-PNEUMINE AMINOPHYLLINE ADULTES	G	Amyleine HCl - 0.01g, Eucalyptol - 0.05g, Camphre - 0.1g, Gaiacol ethyl glycolate - 0.26g, Aminophylline - 0.15g	Suppository	326,362 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE F	G	Potassium chloride - 3.914g/l, Magnesium chloride, 6H2O - 3.558g/l, Calcium chloride, 2H2O - 7.719g/l, Acetic acid 100% - 6.010ml/l, Sodium chloride - 208.631g/l	Injectable solution	L.L
R03DA55	CAMPHO-PNEUMINE AMINOPHYLLINE ADULTES	G	Amyleine HCl - 0.01g, Eucalyptol - 0.05g, Camphre - 0.1g, Gaiacol ethyl glycolate - 0.26g, Aminophylline - 0.15g	Suppository	490,183 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE SG	G	Potassium chloride - 3.92g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 166.7g/l, Sodium chloride - 214.76g/l	Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS L	G	Potassium chloride - K+:1.5 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:106.5 mmol/l, Sodium chloride - Na+:135 mmol/l	Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LM	G	Potassium chloride - K+:2.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:112 mmol/l, Sodium chloride - Na+:140 mmol/l	Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LS	G	Potassium chloride - K+:1.5 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:111.5 mmol/l, Sodium chloride - Na+:140 mmol/l	Injectable solution	L.L

...